FRESENIUS MEDICAL CARE AG/ DE0005785802 /
| 2024-11-15 5:29:50 PM | Chg. +0.85 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 41.65EUR | +2.08% | 285 Turnover: 1.14 mill. |
-Bid Size: - | -Ask Size: - | 12.19 bill.EUR | 2.86% | 24.44 |
Assets
|
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 4,190.3000 | 4,056.9000 | 4,235 | 4,152.7000 | 3,782.7800 | ||||||
| Intangible Assets | 1,426.3000 | 1,381 | 1,459.4000 | 1,518.7000 | 1,362.3200 | ||||||
| Long-Term Investments | 696.9000 | 761.1000 | 786.9000 | 773.7000 | 642.9200 | ||||||
| Fixed Assets | - | - | - | 27,550.7000 | 25,228.3900 | ||||||
| Inventories | 1,663.3000 | 1,895.3000 | 2,038 | 2,296.2000 | 2,179.1700 | ||||||
| Accounts Receivable | 3,421.3000 | 3,153 | 3,409.1000 | 3,714.3000 | 3,471.2100 | ||||||
| Cash and Cash Equivalents | 1,007.7000 | 1,081.5000 | 1,481.7000 | 1,273.8000 | 1,403.4900 | ||||||
| Current Assets | 7,165.1000 | 7,275.3000 | 7,967.2000 | 8,203.5000 | 8,701.4900 | ||||||
| Total Assets | 32,934.7000 | 31,689 | 34,366.6000 | 35,754.1000 | 33,929.8000 | ||||||
Liabilities
|
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 716.5000 | 732 | 736.1000 | 931.3000 | 885.1300 | ||||||
| Long-term debt | - | - | - | 11,175.7000 | 6,959.8600 | ||||||
| Liabilities to Banks | 1,150 | 63 | 1,178.4000 | - | - | ||||||
| Provisions | 739.7000 | 785.9000 | 868.5000 | 5,475.5000 | 2,700.5200 | ||||||
| Liabilities | 19,707.5000 | 19,357.7000 | 20,387.5000 | 20,304.9000 | 19,103.2700 | ||||||
| Share Capital | 304.4370 | 292.8770 | 293.0040 | - | - | ||||||
| Total Equity | 11,957.9000 | 11,215.1000 | 12,698.8000 | 15,449.2000 | 13,620.2600 | ||||||
| Minority Interests | 1,269.3000 | 1,116.2000 | 1,280.3000 | 1,459.7000 | 1,206.2700 | ||||||
| Total liabilities equity | 32,934.7000 | 31,689 | 34,366.6000 | 35,754.1000 | 33,929.8000 | ||||||
Income Statement
|
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 17,476.6000 | 17,859.1000 | 17,618.7000 | 19,398 | 19,453.6100 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 2,269.6000 | 2,304.4000 | 1,852.3000 | 1,511.8000 | 1,369.4300 | ||||||
| Interest Income | -429.5000 | -368 | -280.4000 | -292.4000 | -336.4300 | ||||||
| Income Before Taxes | 1,840.1000 | 1,936.4000 | 1,571.9000 | 1,219.3000 | 1,033.0100 | ||||||
| Income Taxes | 401.6000 | 500.6000 | 352.8000 | 325 | 300.5500 | ||||||
| Minority Interests Profit | -238.9000 | -271.5000 | -249.7000 | -220.9000 | 233.4600 | ||||||
| Net Income | 1,199.6000 | 1,164.4000 | 969.3000 | 673.4000 | 498.9900 | ||||||
Per Share
Cash Flow
|
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2,567 | 4,233.2000 | 2,489.5000 | 2,167.4000 | 2,628.8000 | ||||||
| Cash Flow from Investing Activities | -3,286 | -1,334.9000 | -1,196.2000 | -734.7000 | -544.2200 | ||||||
| Cash Flow from Financing | -466.6000 | -2,664 | -1,024.4000 | -1,617.4000 | -1,858.5200 | ||||||
| Decrease / Increase in Cash | -1,137.9000 | 73.8000 | 400.1000 | - | - | ||||||
| Employees | 120,659 | 125,364 | 122,909 | 128,044 | 119,845 | ||||||
